Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Haines

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|April 5, 2011
Rituximab maintenance therapy for follicular lymphomaIan Haines
Lancet (London, England)|October 31, 2008
Docetaxel for hormone-refractory prostate cancerIan Haines
Australian Prescriber|October 30, 2016
Costs and concerns in cancer careIan Haines
Lancet (London, England)|June 3, 2014
The war on cancer: time for a new terminologyIan Haines
Lancet (London, England)|April 2, 2013
Postoperative radiotherapy for high-risk prostate cancerIan Haines
Lancet (London, England)|January 18, 2011
Rituximab-containing therapy for chronic lymphocytic leukaemiaIan Haines, Patrick Elliott, Robert Stanley
Lancet (London, England)|May 2, 2015
Prostate cancer screening in EuropeIan Haines, Richard J Ablin, George L Gabor Miklos
The Journal of Physical Chemistry Letters|April 3, 2026
Mechanistic Principles of Exciton-Polariton RelaxationIan Haines, Arshath Manjalingal, Logan Blackham, et al.
Public Health Research & Practice|August 3, 2017
PSA testing for men at average risk of prostate cancerBruce K Armstrong, Michael J Barry, Mark Frydenberg, et al.
Internal Medicine Journal|May 10, 2017
Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in AustraliaYeh Chen Lee, René Kroon, Bogda Koczwara, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|April 5, 2011
Rituximab maintenance therapy for follicular lymphomaIan Haines
Lancet (London, England)|October 31, 2008
Docetaxel for hormone-refractory prostate cancerIan Haines
Australian Prescriber|October 30, 2016
Costs and concerns in cancer careIan Haines
Lancet (London, England)|June 3, 2014
The war on cancer: time for a new terminologyIan Haines
Lancet (London, England)|April 2, 2013
Postoperative radiotherapy for high-risk prostate cancerIan Haines
Lancet (London, England)|January 18, 2011
Rituximab-containing therapy for chronic lymphocytic leukaemiaIan Haines, Patrick Elliott, Robert Stanley
Lancet (London, England)|May 2, 2015
Prostate cancer screening in EuropeIan Haines, Richard J Ablin, George L Gabor Miklos
The Journal of Physical Chemistry Letters|April 3, 2026
Mechanistic Principles of Exciton-Polariton RelaxationIan Haines, Arshath Manjalingal, Logan Blackham, et al.
Public Health Research & Practice|August 3, 2017
PSA testing for men at average risk of prostate cancerBruce K Armstrong, Michael J Barry, Mark Frydenberg, et al.
Internal Medicine Journal|May 10, 2017
Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in AustraliaYeh Chen Lee, René Kroon, Bogda Koczwara, et al.
Pageof 2